- ►annals.org [PDF] FA McAlister, JA Ezekowitz, N Wiebe, B Rowe … - Annals of internal medicine, 2004 - Am Coll Physicians Background: Even with optimal pharmacotherapy, symptomatic heart failure is
associated with substantial morbidity and mortal- ity. Purpose: To determine the
efficacy and safety of cardiac resyn- chronization therapy in adults with ... Cited by 221 - Related articles - BL Direct - All 6 versions
- ►onlinejacc.org RG Assomull, SK Prasad, J Lyne, G Smith, … - Journal of the American College of Cardiology, 2006 - Elsevier Risk stratification of patients with nonischemic DCM in the era of device
implantation is problematic. Approximately 30% of patients with DCM have midwall
fibrosis as detected by late gadolinium-enhancement (LGE) cardiovascular ... Cited by 141 - Related articles - BL Direct - All 38 versions
FA McAlister, J Ezekowitz, N Hooton, B … - Jama, 2007 - Am Med Assoc Evidence Acquisition A search of multiple electronic databases until November
2006 was supplemented by hand searches of reference lists of included studies
and review articles, proceedings booklets from meetings, FDA reports, and ... Cited by 96 - Related articles - BL Direct - All 8 versions
- ►ispm-unibasel.ch [PDF] C Mueller, K Laule-Kilian, C Schindler, T … - Archives of Internal Medicine, 2006 - archinte.highwire.org Methods We performed a prospective randomized study (B-Type Natriuretic Peptide
for Acute Shortness of Breath Evaluation) including 452 patients who presented
to the emergency department with acute dyspnea to estimate the long-term ... Cited by 70 - Related articles - BL Direct - All 6 versions
- ►onlinejacc.org [PDF] AM Feldman, G de Lissovoy, MR Bristow, LA … - Journal of the American College of Cardiology, 2005 - Elsevier The analysis goal was to estimate incremental cost-effectiveness ratios (ICERs)
for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart
Failure (COMPANION) trial patients who received cardiac resynchronization ... Cited by 62 - Related articles - BL Direct - All 7 versions
RG Trohman, MH Kim, SL Pinski - The Lancet, 2004 - Elsevier Permanent cardiac pacing remains the only effective treatment for chronic,
symptomatic bradycardia. In recent years, the role of implantable pacing devices
has expanded substantially. At the beginning of the 21st century, exciting ... Cited by 57 - Related articles - All 12 versions
- ►oxfordjournals.org G Yao, N Freemantle, MJ Calvert, S Bryan, JC … - European heart journal, 2007 - Eur Soc Cardiology Methods and results A Markov model with Monte Carlo simulation to assess costs,
life years, and QALYs associated with CRT (± ICD) and MT in patients with heart
failure and cardiac dyssynchrony, on the basis of a UK healthcare ... Cited by 52 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org MJ Calvert, N Freemantle, G Yao, JGF Cleland, … - European heart journal, 2005 - Eur Soc Cardiology Methods and results This prospective analysis based on intention to treat data
from all patients enrolled in the CARE-HF trial at 82 clinical centres in 12
European countries. A total of 813 patients with New York Heart Association ... Cited by 51 - Related articles - BL Direct - All 6 versions
G Boriani, CP Müller, KH Seidl, R Grove, J … - American Heart Journal, 2006 - Elsevier RHYTHM II was a single-blind randomized trial including 121 recipients of a
device for CRT with cardioverter/defibrillator capabilities (CRT-D) randomly
assigned in a 1:3 ratio to simultaneous (n = 30) versus optimized (OPT) (n ... Cited by 51 - Related articles - All 9 versions
- ►annals.org [PDF] JT Berger - Annals of internal medicine, 2005 - Am Coll Physicians Implantable cardioverter defibrillators are life-saving devices for many
patients with cardiac disease. Recipients of these devices, nevertheless, often
suffer from progressive comorbid and cardiac conditions. Therefore, ... Cited by 27 - Related articles - All 5 versions
